The Advances of Treatment for Pulmonary Mycosis
10.3870/j.issn.1004-0781.2001.01.015
- VernacularTitle:肺真菌病治疗进展
- Author:
Dong LI
- Publication Type:Journal Article
- From:
Herald of Medicine
2001;(1):28-29
- CountryChina
- Language:Chinese
-
Abstract:
In this paper, the advances of the treatment for the most common pulmonary mycosis is introduced, and the recommended medications described. It is indicated that amphotericin B is still the first choice for the treatment of severe and rapidly progressive pulmonary mycosis. Lipid formulations of AmB can be used for those refractory or intolerant to the conventional amphotericin B. Fluconazole has proved effective in treating pulmonary candidosis, cryptococosis and coccidioidomysis. Itraconazole has been widely used in the treatment of pulmonary aspergillosis, histoplasmosis ans coccidioidomycosis.
